Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardiac Science Aims To Recoup Japan Losses With Biphasic AEDs

This article was originally published in The Gray Sheet

Executive Summary

Cardiac Science expects to regain share of the Japanese automatic external defibrillator market with the launch of its biphasic AEDs in Japan, according to CEO Raymond Cohen

You may also be interested in...



Supporting Japan Applications With U.S. Data Is Slower, But Worth It – AGA

AGA Medical will support its second regulatory application in Japan with U.S. data - despite the Japanese health ministry's preference for domestic data - because Japanese trials are prohibitively expensive, according to CEO Franck Gougeon

Cardiac Science To Challenge Philips As Sole Biphasic AED Player In Japan

Cardiac Science anticipates receiving approval from the Japanese Ministry of Health, Labour & Welfare for a biphasic automated external defibrillator by the end of Q2, the firm says

Finance Watch: Silverback, Kinnate, Sigilon Launch December’s First IPOs

Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel